Numerate receives NIH funding to discover new anti-arrhythmic treatments

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a small business innovation research (SBIR) Phase I grant to Numerate to boost a new drug programme for cardiac arrhythmias.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news